Brzezińska Natalia, Bulińska Barbara, Zawadzka Natalia, Roter Gustaw, Szczerkowska-Dobosz Aneta
Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Postepy Dermatol Alergol. 2024 Oct;41(5):479-486. doi: 10.5114/ada.2024.144417. Epub 2024 Oct 22.
Acne vulgaris is a highly prevalent skin disorder, driving the ongoing search for innovative treatment modalities. While numerous studies have demonstrated the effectiveness of photodynamic therapy (PDT) in managing acne vulgaris, there remains a lack of clear guidlines regarding optimal treatment parameters.
To assess the efficacy and safety of 10% concentration 5-aminolevulinic acid-(ALA) in comparison to 15% ALA PDT for treating facial acne vulgaris.
A randomized, double-blind, split-face clinical trial was conducted on 25 patients with moderate to severe acne (). Patients were randomly assigned to two groups with different ALA concentrations applied on one cheek, while a placebo was applied on the other side. After a 1.5-hour incubation, illumination with 633 nm red light from a Light Emitting Diode (LED) lamp (96 J/cm) was performed in three sessions with 7-10 days' intervals. Treatment effectiveness was assessed by the lesion reduction rate based on lesion counts before the study, after each session, and at 4 and 8 weeks after the last session.
Both 15% and 10% ALA-PDT treatments demonstrated significant reductions in inflammatory acne lesion counts compared to the placebo: 10% ALA-PDT showed a reduction of 27.36% versus 12.64% for the placebo ( = 0.04), while 15% ALA-PDT showed a reduction of 40.45% compared to 13.41% ( < 0.01). However, there was no significant difference between ALA-PDT and placebo in treating non-inflammatory lesions. Additionally, there was no difference between the effectiveness of 10% and 15% ALA in reducing any type of acne lesions.
ALA-PDT is effective in treating acne vulgaris. However, ALA-PDT provides an advantage over red light only for inflammatory acne lesions. The study indicates that higher concentrations of ALA do not result in more significant reductions in acne lesions.
寻常痤疮是一种非常常见的皮肤疾病,促使人们不断寻求创新的治疗方法。虽然众多研究已证明光动力疗法(PDT)在治疗寻常痤疮方面的有效性,但关于最佳治疗参数仍缺乏明确的指南。
评估10%浓度的5-氨基酮戊酸(ALA)与15% ALA PDT治疗面部寻常痤疮的疗效和安全性。
对25例中度至重度痤疮患者进行了一项随机、双盲、半脸临床试验。患者被随机分为两组,在一侧脸颊上涂抹不同浓度的ALA,另一侧涂抹安慰剂。在孵育1.5小时后,使用发光二极管(LED)灯发出的633 nm红光(96 J/cm)进行照射,分三次进行,间隔7 - 10天。根据研究前、每次治疗后以及最后一次治疗后4周和8周的皮损计数,通过皮损减少率评估治疗效果。
与安慰剂相比,15%和10% ALA - PDT治疗均使炎性痤疮皮损计数显著减少:10% ALA - PDT显示减少27.36%,而安慰剂组减少12.64%(P = 0.04);15% ALA - PDT显示减少40.45%,安慰剂组减少13.41%(P < 0.01)。然而,在治疗非炎性皮损方面,ALA - PDT与安慰剂之间无显著差异。此外,10%和15% ALA在减少任何类型痤疮皮损的有效性方面没有差异。
ALA - PDT在治疗寻常痤疮方面有效。然而,ALA - PDT仅在治疗炎性痤疮皮损方面比单纯红光具有优势。该研究表明,更高浓度的ALA并不会使痤疮皮损有更显著的减少。